{"id":3845,"date":"2022-11-06T13:37:19","date_gmt":"2022-11-06T13:37:19","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=3845"},"modified":"2023-07-11T13:46:37","modified_gmt":"2023-07-11T13:46:37","slug":"west-african-journal-of-pharmacy-2022-33-1-62-71","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2022-33-1-62-71\/","title":{"rendered":"West African Journal of Pharmacy (2022) 33 (1) 62 – 71"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Inhibition of potassium sensitive adenosine triphosphate channels potentiates anti-depressant\u00a0<\/b>activity of creatine in mice<\/b><\/p>

\u00a0<\/b><\/p>

Emmanuel O. Okwuofu , Loretta O. Iniaghe , Bukhari Mahmud , Edu Oluwatimileyin<\/p>

1Department of Pharmacology and Toxicology, College of Pharmacy, Igbinedion University, Okada, Edo State, Nigeria<\/p>

2Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria<\/p>

3Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Ahmadu Bello University,\u00a0Zaria, Kaduna State, Nigeria.<\/span><\/p>

\u00a0<\/span><\/p>

Corresponding author: Loretta O. Iniaghe<\/p>

Email: lo.iniaghe@uniben.edu<\/p>

Phone: +2348022113816<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background:<\/strong> Depression is a mood disorder with poorly understood aetiology and treatment outcomes. Treatment with creatine, a nutraceutical associated with potassium sensitive adenosine triphosphate channels (KATP), produced improved results in preclinical studies of depression.<\/p>

Objective:<\/strong> This study sought to investigate the role of KATP inhibitor and activator on the antidepressant activity of creatine in mice.<\/p>

Methods:<\/strong> Four hundred and ninety male mice randomly allotted into groups of seven were either untreated (na\u00efve) or pretreated with effective or sub-effective doses of glibenclamide or cromakalim, followed by selected doses of creatine, amitriptyline or imipramine for fourteen consecutive days. Groups of na\u00efve and treated animals were thereafter subjected to forced swim test (FST) or tail suspension test (TST) or open field test (OFT).<\/p>

Results:<\/strong> Pretreatment with effective or subeffective doses of glibenclamide and creatine, imipramine or amitriptyline significantly (p<0.05) reduced duration of immobility in the TST and FST. Conversely, cromakalim administered in combination with creatine, imipramine and amitriptyline antagonized the antidepressant effect of creatine, imipramine and amitriptyline. However, there was no difference in locomotor activity in the OFT across the treatment groups.<\/p>

Conclusion:<\/strong> Inhibition of KATP channels potentiates the antidepressant activity of creatine.<\/p>

Keywords:<\/strong> Creatine, KATP, antidepressant, cromakalim and glibenclamide<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Inhibition of potassium sensitive adenosine triphosphate channels potentiates anti-depressant\u00a0activity of creatine in mice \u00a0 Emmanuel O. Okwuofu , Loretta O. Iniaghe , Bukhari Mahmud , Edu Oluwatimileyin 1Department of Pharmacology and Toxicology, College of Pharmacy, Igbinedion University, Okada, Edo State, Nigeria 2Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[209],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/3845"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=3845"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/3845\/revisions"}],"predecessor-version":[{"id":3851,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/3845\/revisions\/3851"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=3845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=3845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=3845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}